Edition:
United States

Fuji Pharma Co Ltd (4554.T)

4554.T on Tokyo Stock Exchange

3,870JPY
21 Jul 2017
Change (% chg)

¥-45 (-1.15%)
Prev Close
¥3,915
Open
¥3,915
Day's High
¥3,915
Day's Low
¥3,850
Volume
15,900
Avg. Vol
28,251
52-wk High
¥4,170
52-wk Low
¥2,283

Latest Key Developments (Source: Significant Developments)

Mithra Pharmaceuticals signs license and exclusive supply agreement with Fuji Pharma
Wednesday, 28 Jun 2017 02:07am EDT 

June 28 (Reuters) - MITHRA PHARMACEUTICALS SA ::SIGNS LICENSE AND EXCLUSIVE SUPPLY AGREEMENT WITH FUJI PHARMA FOR DONESTA IN JAPAN AND ASEAN.DONESTA IS PRODUCT OF MITHRA IN HORMONE THERAPY (HT), WHOSE PHASE II DOSE RESEARCH STUDY IS CURRENTLY UNDERWAY, MAIN RESULTS ARE EXPECTED AT END Q1 2018.CO IS ENTITLED TO EUR 1 MILLION FOR SIGNING, IN ADDITION TO FUTURE TWO-DIGIT MILESTONES RELATED TO DEVELOPMENT, REGULATORY ASPECTS AND COMMERCIALIZATION.  Full Article

Mithra Pharmaceuticals signs binding term sheet with Fuji Pharma to commercialize Donesta in Japan and ASEAN
Thursday, 2 Mar 2017 01:54am EST 

Mithra Pharmaceuticals SA : Announced on Wednesday signing of a binding term sheet with the Japanese leader in women's health Fuji Pharma <4554.T> to commercialize Donesta in Japan and ASEAN . The 20-year partnership agreement, which includes an exclusive supply agreement by Mithra's CDMO2, should generate single-digit upfront milestones . More details on the deal will be communicated when the full and complete LSA is finalized . Mithra also provides an update on its Phase II program for Donesta; has decided to extend the protocol of its Phase II study .Regulatory approval of the new protocol is expected towards the end of Q1 2017. The Phase II study is now expected to be completed in Q1 2018, and topline results of the Phase II study should be available late Q1 2018.  Full Article

Mithra Pharmaceuticals signs LOI for estetrol with Fuji Pharmaceuticals
Friday, 24 Jun 2016 03:17am EDT 

Mithra Pharmaceuticals SA : Signs a Letter of Intent with Fuji Pharmaceuticals to work towards a broad partnership on Estetrol in women's health, in multiple indications to be determined in common agreement . Both parties intend to finalize their partnership in an agreement before end of this year .Indicative financial terms are being discussed, which offer the potential for milestones in the double-digit million euro range.  Full Article

Fuji Pharma announces change of chairman and president
Friday, 26 Feb 2016 01:00am EST 

Fuji Pharma Co Ltd:Appoints Eiji Takemasa as new president to succeed Hirofumi Imai.Appoints Hirofumi Imai as chairman of the board.Effective April 1.  Full Article

BRIEF-Mithra Pharmaceuticals signs license and exclusive supply agreement with Fuji Pharma

* SIGNS LICENSE AND EXCLUSIVE SUPPLY AGREEMENT WITH FUJI PHARMA FOR DONESTA IN JAPAN AND ASEAN